Product Images Dilantin-125

This is a label indicating that a product was distributed by Parke-Davis, which is the division of Pfizer Inc. located in NY, NY 10017.*

This is a text indicating that a particular product is distributed by Parke-Davis, which is a division of Pfizer Inc located at NY, NY 10017.*

Dilantin-125 is an oral suspension medication used to treat seizures. Patients should shake the bottle well before every use and a calibrated measuring device is advised to ensure accurate dosage. One teaspoon is recommended for adults three times daily, while pediatric patients need to follow the instructions given in the package insert. The maximum alcohol content is no more than 0.6%. The medication must be stored between 20°C to 25°C and kept away from light and freezing temperatures. It is essential to follow the medication guide provided for additional information. The distributing company is Parke-Davis, a division of Pfizer Inc.*

This is a prescription medication with the brand name Dilantin-125 Oral Suspension. It contains phenytoin, a drug used to control seizures in adults. Each 5 mL of the medication has 125 mg of phenytoin and a maximum alcohol content of 0.6%. The medication should be shaken well before each use, and an adequate measuring device should be used to ensure accuracy. The package insert contains complete prescribing information. The medication must be stored at 20°C to 25°C, protected from light, and kept out of reach of children. The label also emphasizes that there is no copy, no varnish, and no ink on the packaging.*

Dilantin-125 is an oral suspension medication that contains phenytoin, used for the treatment of seizures. The medication guide must always be dispensed with the drug. The product should be shaken well before each use and not used for injections. The maximum alcohol content is 0.6 percent. The dosage for adults is 1 teaspoonful (5 mL) three times daily, while for pediatric patients, the package insert should be consulted. It is important to use a recommended measuring device to deliver the correct dose. The product should be stored at room temperature and protected from light. Parke-Davis, a division of Pfizer Inc., distributes Dilantin-125.*

This is a medication package for Dilantin-125, an oral suspension used to treat seizures caused by epilepsy. The package contains important information regarding dosages and usage instructions. The medication should be shaken well before use and should not be used intravenously. The package includes measurements for accurate dosing; household teaspoons or tablespoons are not recommended for this purpose. The package also warns about controlled temperature requirements and the importance of protecting the medication from light and freezing. The medication has an alcohol content of not more than 0.6%. The package is distributed by Parke-Davis, a division of Pfizer Inc.*